Immunization

CDC data shown to overstate US vaccination rates; school-based cognitive behavioral therapy for overwhelmed children; Moderna to develop Omicron-specific COVID-19 booster dose.

Learn how the challenges and opportunities of the last year have impacted independent pharmacy professionals around the world.

The Johnson & Johnson vaccine is staying on the market, but the preference for the Pfizer and Moderna mRNA vaccines stems from concerns about the rare but real risk of blood clots from the J&J vaccine.

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.

Questions continue to swirl around eligibility for these shots.

The US FDA has accepted a Priority Review of the pneumococcal 15-valent conjugate vaccine VAXNEUVANCE™ in children aged 17 years and younger.

PreHevbrio is the only 3-antigen vaccine for Hepatitis B approved for adults

Educate patients about the safety of receiving the seasonal influenza and COVID-19 vaccine at the same time.

When administered at the same time, patients may misattribute adverse effects of the recombinant zoster vaccine to the flu vaccine.

Kristen Nichols, PharmD, and senior content management consultant for clinical effectiveness at Wolters Kluwer joins Drug Topics® to discuss holiday burnout in part 3 of this interview.

Kristen Nichols, PharmD, and senior content management consultant for clinical effectiveness at Wolters Kluwer joins Drug Topics® to discuss the benefits of the coadministration of COVID-19 and flu vaccines in part 2 of this interview.

The Omicron variant was first identified in South Africa on November 24, 2021.

Nearly one-third of hospital personnel had still not been vaccinated against COVID-19 by mid-September.

State legislation that allows adolescents to choose to receive the HPV vaccine without parental interference would elevate immunization rates, according to a new study.

Not every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.

Influenza vaccination may be associated with lower risks of ventricular arrhythmia in patients with chronic obstructive pulmonary disease.

The vaccine mandate applies to employees at facilities that participate in the Medicare and Medicaid insurance programs.

Vaccine technologies in development may facilitate a rapid and effective response to new threats and likely will target not only infectious diseases but also allergies, autoimmune conditions, and cancers.

A study examines whether an intervention that promotes including teenagers in the decision-making process for getting vaccines leads to better outcomes, such as vaccine literacy.

The company plans to submit these results to the FDA and EMA for review.

After a panel federal judges put a temporary halt on the mandate, the U.S. Surgeon General says the administration is ready to fight for the requirement.

Patients with rheumatoid arthritis should be encouraged to receive their yearly flu vaccine.

Pharmacists in 2 states are now empowered to administer FDA approved, CDC recommended vaccines.

The vaccine’s safety, tolerability, and efficacy was discussed across multiple abstracts presented at ACR Convergence 2021.

Following a booster shot, immunoglobulin G titers increased significantly in a study population aged 60 years and older.

Ocugen, Inc. has submitted a request to the FDA for emergency use authorization (EUA) of their COVID-19 vaccine candidate for use in children aged 2 to 18 years.

To date, the best recombinant zoster vaccine (Shingrix) is the best protection against shingles and its complications.

The FDA has notified Moderna that it will need additional time to complete its evaluation of Moderna’s EUA request for the use of the company’s COVID-19 vaccine at the 100-µg dose level in adolescents between 12 and 17 years.

The next step in the approval process is the formal acceptance of the recommendation by CDC Director Rochelle P. Walensky, MD, MPH.

The US Food and Drug Administration (FDA) committee voted on whether the emergency use authorization should be extended to children aged 5 to 11 years.